AFM
APTO

Abbot Financial Management’s Aptose Biosciences, Inc. APTO Stock Holding History

Abbot Financial Management’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-22
Closed -$22K – 138
2021
Q3 		$22K Hold
22
– – 0.01% 134
2021
Q2 		$33K Hold
22
– – 0.01% 132
2021
Q1 		$60K Buy
+22
New +$43.6K 0.03% 132

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Abbot Financial Management's APTO Position: Q4 2021 in Review

Abbot Financial Management sold out of Aptose Biosciences, Inc. (APTO) in Q4 2021, closing a stake of 22 shares — an estimated $22K sold.

Abbot Financial Management first reported a position in APTO in Q1 2021 and held it in 3 quarters. The position peaked at $60K in Q1 2021. 58 funds tracked by Wall St. Rank hold APTO as of Q4 2021.

  • Abbot Financial Management reported no remaining Aptose Biosciences, Inc. position as of Q4 2021 after selling out during the quarter.
  • Abbot Financial Management sold 22 Aptose Biosciences, Inc. shares in Q4 2021, an estimated $22K.
  • Abbot Financial Management first reported a position in Aptose Biosciences, Inc. in Q1 2021 and held it in 3 quarters.
  • Abbot Financial Management's Aptose Biosciences, Inc. position peaked at $60K in Q1 2021.
  • 58 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q4 2021.

Based on Abbot Financial Management's 13F filing for Q4 2021, filed 15 Feb 2022.